TY  - JOUR
T1  - CLarification of conflict of interest disclosures
AU  - Kruszewski SP
Y1  - 2012/12/05
N1  - 10.1001/jama.2012.71214
JO  - JAMA
SP  - 2186
EP  - 2187
VL  - 308
IS  - 21
N2  - 
To the Editor: In a Viewpoint on preventing depression,1 Dr Reynolds reported the following disclosures: “Dr Reynolds reports receiving pharmaceuticals for research studies from Bristol-Myers Squibb, Forest, Pfizer, and Lilly.” Subsequently, after notification that he had submitted incomplete conflict of interest (COI) disclosures, Reynolds amended his disclosures, adding government and private funding sources, and indicating “a misunderstanding of the requirements for reporting of conflicts of interest.”2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.71214
UR  - http://dx.doi.org/10.1001/jama.2012.71214
ER  -